Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-Blind Study to Compare the Efficacy and Safety of Patient-Initiated Famciclovir 1000 mg b.i.d x 1 Day to Valacyclovir 500 mg b.i.d. x 3 Days in Immunocompetent Adults with Recurrent Genital Herpes

Project: Research

Project Details

StatusFinished
Effective start/end date10/19/0606/21/07

Funding

  • Novartis Pharmaceuticals Corporation: $1.00